VENKYS (INDIA)
|
VENKYS (INDIA) Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 82.78 | 56.13 | 50.03 | 116.97 | 190.05 |
| CEPS(Rs) | 108.85 | 80.97 | 75.21 | 142.93 | 215.21 |
| DPS(Rs) | 10.00 | 7.00 | 6.00 | 13.00 | 17.00 |
| Book NAV/Share(Rs) | 1,047.44 | 972.67 | 921.82 | 886.49 | 783.98 |
| Tax Rate(%) | 28.33 | 27.74 | 26.04 | 27.25 | 25.76 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 5.19 | 3.30 | 2.64 | 5.55 | 12.47 |
| EBIT Margin(%) | 5.41 | 3.41 | 2.69 | 5.55 | 12.49 |
| Pre Tax Margin(%) | 4.92 | 2.93 | 2.25 | 5.15 | 11.57 |
| PAT Margin (%) | 3.53 | 2.12 | 1.66 | 3.74 | 8.59 |
| Cash Profit Margin (%) | 4.64 | 3.05 | 2.50 | 4.58 | 9.73 |
| Performance Ratios | |||||
| ROA(%) | 5.60 | 3.85 | 3.56 | 8.82 | 15.81 |
| ROE(%) | 8.20 | 5.93 | 5.53 | 14.00 | 27.59 |
| ROCE(%) | 11.27 | 8.45 | 7.78 | 17.90 | 32.10 |
| Asset Turnover(x) | 1.59 | 1.82 | 2.14 | 2.36 | 1.84 |
| Sales/Fixed Asset(x) | 3.09 | 3.69 | 4.34 | 4.60 | 3.42 |
| Working Capital/Sales(x) | 4.07 | 5.77 | 6.25 | 6.94 | 6.69 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.32 | 0.27 | 0.23 | 0.22 | 0.29 |
| Receivable days | 70.02 | 66.95 | 55.81 | 42.67 | 49.12 |
| Inventory Days | 23.15 | 17.97 | 16.42 | 16.71 | 19.29 |
| Payable days | 54.07 | 53.93 | 44.24 | 38.44 | 60.14 |
| Valuation Parameters | |||||
| PER(x) | 19.52 | 27.41 | 28.84 | 18.29 | 8.18 |
| PCE(x) | 14.84 | 19.00 | 19.19 | 14.97 | 7.22 |
| Price/Book(x) | 1.54 | 1.58 | 1.57 | 2.41 | 1.98 |
| Yield(%) | 0.62 | 0.45 | 0.42 | 0.61 | 1.09 |
| EV/Net Sales(x) | 0.68 | 0.60 | 0.48 | 0.69 | 0.69 |
| EV/Core EBITDA(x) | 10.44 | 13.75 | 13.63 | 10.87 | 5.10 |
| EV/EBIT(x) | 12.58 | 17.52 | 17.88 | 12.50 | 5.57 |
| EV/CE(x) | 1.37 | 1.45 | 1.37 | 1.57 | 1.21 |
| M Cap / Sales | 0.69 | 0.58 | 0.48 | 0.69 | 0.70 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -11.53 | -11.70 | -3.79 | 41.19 | -4.43 |
| Core EBITDA Growth(%) | 32.70 | 8.96 | -46.82 | -33.90 | 2,919.28 |
| EBIT Growth(%) | 40.32 | 12.16 | -53.39 | -37.28 | 2,027.30 |
| PAT Growth(%) | 47.49 | 12.18 | -57.23 | -38.45 | 1,085.69 |
| EPS Growth(%) | 47.49 | 12.18 | -57.23 | -38.45 | 1,085.69 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.11 | 0.12 | 0.14 | 0.15 | 0.16 |
| Current Ratio(x) | 2.53 | 1.97 | 2.02 | 1.99 | 1.74 |
| Quick Ratio(x) | 2.06 | 1.71 | 1.72 | 1.70 | 1.40 |
| Interest Cover(x) | 10.96 | 7.02 | 6.16 | 13.89 | 13.66 |
| Total Debt/Mcap(x) | 0.07 | 0.08 | 0.09 | 0.06 | 0.08 |
Compare Financial Ratios of peers of VENKYS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENKYS (INDIA) | ₹2,067.3 Cr | -1.7% | -1.6% | -21.5% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,327.1 Cr | 3.5% | 1.7% | -29.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,442.8 Cr | -1.3% | -7.5% | 15.7% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,268.8 Cr | -3.5% | -11.1% | -31.1% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹558.3 Cr | -1.1% | 12.3% | NA | Stock Analytics | |
| INDO US BIOTECH | ₹259.3 Cr | -3.8% | -11.2% | -51.3% | Stock Analytics | |
VENKYS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENKYS (INDIA) | -1.7% |
-1.6% |
-21.5% |
| SENSEX | 0.1% |
0.6% |
0.7% |
You may also like the below Video Courses
